journal
Journals Journal of the American Colleg...

Journal of the American College of Cardiology

https://read.qxmd.com/read/37734459/implementation-of-global-hearts-hypertension-control-programs-in-32%C3%A2-low-%C3%A2-and%C3%A2-middle-income-countries-jacc-international
#1
REVIEW
Andrew E Moran, Reena Gupta
In 2017, the World Health Organization (WHO) and Resolve to Save Lives partnered with country governments and other stakeholders to design, test, and scale up the WHO HEARTS hypertension services package in 32 low- and middle-income countries. Facility-based HEARTS performance indicators included number of patients enrolled, number treated and with blood pressure controlled, number who missed a scheduled follow-up visit, and number lost to follow-up. By 2022, HEARTS hypertension control programs treated 12...
September 19, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37676197/reducing-mortality-and-cardiovascular%C3%A2-disease-stepping-up-our-game
#2
EDITORIAL
Carl J Lavie, Charles A German, Fabian Sanchis-Gomar
No abstract text is available yet for this article.
August 28, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37676198/relationship-of-daily-step-counts-to%C3%A2-all-cause-mortality-and-cardiovascular%C3%A2-events
#3
JOURNAL ARTICLE
Niels A Stens, Esmée A Bakker, Asier Mañas, Laurien M Buffart, Francisco B Ortega, Duck-Chul Lee, Paul D Thompson, Dick H J Thijssen, Thijs M H Eijsvogels
BACKGROUND: The minimal and optimal daily step counts for health improvements remain unclear. OBJECTIVES: A meta-analysis was performed to quantify dose-response associations of objectively measured step count metrics in the general population. METHODS: Electronic databases were searched from inception to October 2022. Primary outcomes included all-cause mortality and incident cardiovascular disease (CVD). Study results were analyzed using generalized least squares and random-effects models...
August 26, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37634707/dapagliflozin-in-patients-with-heart-failure-and-deterioration-in-estimated-glomerular-filtration-rate-to-25ml-min-1-73m-2
#4
JOURNAL ARTICLE
Safia Chatur, Muthiah Vaduganathan, Brian L Claggett, Finnian R Mc Causland, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, Adrian F Hernandez, Silvio E Inzucchi, Mikhail N Kosiborod, Carolyn S P Lam, Felipe A Martinez, Sanjiv J Shah, Marc S Sabatine, Lars Kober, Piotr Ponikowski, Bela Merkely, Magnus Petersson, Anna Maria Langkilde, John J V McMurray, Scott D Solomon
BACKGROUND: SGLT-2 inhibitors are guideline-recommended in the management of heart failure(HF). While these therapies can be initiated even in patients with comorbid CKD, some patients may face deterioration in kidney function over time. OBJECTIVES: To examine the safety and efficacy of continuing SGLT-2 inhibitors in HF when eGFR falls below thresholds for initiation. METHODS: Associations between a deterioration in eGFR below 25 ml/min/1...
August 23, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37640248/concomitant-coronary-atheroma-regression-and-stabilization-in-response-to-lipid-lowering-therapy
#5
JOURNAL ARTICLE
Flavio G Biccirè, Jonas Häner, Sylvain Losdat, Yasushi Ueki, Hiroki Shibutani, Tatsuhiko Otsuka, Ryota Kakizaki, Thomas M Hofbauer, Robert-Jan van Geuns, Stefan Stortecky, Georgios Cm Siontis, Sarah Bär, Jacob Lønborg, Dik Heg, Christoph Kaiser, David Spirk, Joost Daemen, Juan Iglesias, Stephan Windecker, Thomas Engstrøm, Irene Lang, Konstantinos C Koskinas, Lorenz Räber
BACKGROUND: The frequency, characteristics and outcomes of patients treated with high-intensity lipid-lowering therapy and showing concomitant atheroma volume reduction, lipid content reduction, and increase in fibrous cap thickness (i.e., "triple regression") are unknown. OBJECTIVES: This study was designed to investigate rates, determinants and prognostic implications of triple regression in patients presenting with acute myocardial infarction (AMI) and treated with high-intensity lipid-lowering therapy...
August 20, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37611779/comparison-of-initial-antithrombotic-regimens-after-left-atrial-appendage-occlusion-a-systematic-review-and-network-meta-analysis
#6
JOURNAL ARTICLE
Pedro E P Carvalho, Douglas M Gewehr, Isabele A Miyawaki, Alleh Nogueira, Nicole Félix, Philippe Garot, Arthur Darmon, Patrizio Mazzone, Alberto Preda, Bruno R Nascimento, Luiz F Kubrusly, Rhanderson Cardoso
BACKGROUND: The optimal antithrombotic therapy following left atrial appendage occlusion (LAAO) in patients with nonvalvular atrial fibrillation (AF) remains uncertain. OBJECTIVES: To compare the efficacy and safety of various antithrombotic strategies after LAAO. METHODS: We searched MEDLINE, Cochrane, Embase, LILACS, and ClinicalTrials.gov databases for studies reporting outcomes after LAAO, stratified by antithrombotic therapy prescribed at postprocedural discharge...
August 16, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37610399/the-need-for-global-optimization-of%C3%A2-heart%C3%A2-failure-therapy-some-differences-do-not-matter
#7
EDITORIAL
Javed Butler, Muhammad Shahzeb Khan, Gregg C Fonarow
No abstract text is available yet for this article.
August 2, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37610398/efficacy-of-dapagliflozin-according-to-geographic-location-of-patients-with-heart%C3%A2-failure
#8
JOURNAL ARTICLE
Toru Kondo, Xiaowen Wang, Mingming Yang, Pardeep S Jhund, Brian L Claggett, Muthiah Vaduganathan, Adrian F Hernandez, Carolyn S P Lam, Silvio E Inzucchi, Felipe A Martinez, Rudolf A de Boer, Mikhail N Kosiborod, Akshay S Desai, Lars Køber, Piotr Ponikowski, Marc S Sabatine, Anna Maria Langkilde, Magnus Petersson, Natalia Zaozerska, Erasmus Bachus, Scott D Solomon, John J V McMurray
BACKGROUND: Because clinical characteristics and prognosis vary by geographic region in patients with heart failure (HF), the response to treatment may also vary. A previous report suggested that the efficacy of sodium-glucose cotransporter-2 inhibitor efficacy in heart failure with reduced ejection fraction (HFrEF) may be modified by region. OBJECTIVES: The goal of this study was to examine the efficacy and safety of dapagliflozin in patients with HF according to geographic region...
August 2, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37642609/initiating-mineralocorticoid-antagonists-for-longstanding-heart%C3%A2-failure-with-reduced-ejection-fraction-better-late-than-never
#9
EDITORIAL
Andrew J Sauer, Judith Hsia
No abstract text is available yet for this article.
August 1, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37642608/underutilization-of-mineralocorticoid-antagonists-in-patients-with-heart%C3%A2-failure-with%C3%A2-reduced%C3%A2-ejection-fraction
#10
JOURNAL ARTICLE
Shingo Matsumoto, Toru Kondo, Pardeep S Jhund, Ross T Campbell, Karl Swedberg, Dirk J van Veldhuisen, Stuart J Pocock, Bertram Pitt, Faiez Zannad, John J V McMurray
BACKGROUND: It is unknown how the efficacy and safety of mineralocorticoid receptor antagonists vary according to duration of heart failure with reduced ejection fraction (HFrEF). OBJECTIVES: In this study, we sought to evaluate the safety and efficacy of eplerenone according to duration of HFrEF. METHODS: In the EMPHASIS-HF trial, 3 patient groups were created according to HFrEF duration: <1 year, 1 to <5 years, and ≥5 years...
August 1, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37542484/medical-and-legal-determinants-of-sports-eligibility-for-young-competitive-athletes-with-cardiovascular-disease
#11
JOURNAL ARTICLE
Martin S Maron, Matthew Mitten, James Borchers, Ethan J Rowin, Barry J Maron
No abstract text is available yet for this article.
July 27, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37516945/in-memoriam-wcr-the-remarkable-life-and-works-of-dr-bill-roberts
#12
EDITORIAL
Barry J Maron
No abstract text is available yet for this article.
July 21, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37480922/2023-aha-acc-accp-aspc-nla-pcna-guideline-for-the-management-of-patients-with-chronic%C3%A2-coronary-disease-a-report-of-the-american-heart-association-american-college-of-cardiology-joint-committee-on-clinical-practice-guidelines
#13
Salim S Virani, L Kristin Newby, Suzanne V Arnold, Vera Bittner, LaPrincess C Brewer, Susan Halli Demeter, Dave L Dixon, William F Fearon, Beverly Hess, Heather M Johnson, Dhruv S Kazi, Dhaval Kolte, Dharam J Kumbhani, Jim LoFaso, Dhruv Mahtta, Daniel B Mark, Margo Minissian, Ann Marie Navar, Amit R Patel, Mariann R Piano, Fatima Rodriguez, Amy W Talbot, Viviany R Taqueti, Randal J Thomas, Sean van Diepen, Barbara Wiggins, Marlene S Williams
AIM: The "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease" provides an update to and consolidates new evidence since the "2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease" and the corresponding "2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease." METHODS: A comprehensive literature search was conducted from September 2021 to May 2022...
July 14, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37480921/2023-chronic-coronary-disease-guideline-at-a-glance
#14
David E Winchester
No abstract text is available yet for this article.
July 14, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37462593/impact-of-complete-revascularization-in%C3%A2-the-ischemia-trial
#15
JOURNAL ARTICLE
Gregg W Stone, Ziad A Ali, Sean M O'Brien, Grace Rhodes, Philippe Genereux, Sripal Bangalore, Kreton Mavromatis, Jennifer Horst, Ovidiu Dressler, Kian Keong Poh, Ranjit K Nath, Nagaraja Moorthy, Adam Witkowski, Sudhanshu K Dwivedi, Olga Bockeria, Jiyan Chen, Paola E P Smanio, Michael H Picard, Bernard R Chaitman, Daniel S Berman, Leslee J Shaw, William E Boden, Harvey D White, Stephen E Fremes, Yves Rosenberg, Harmony R Reynolds, John A Spertus, Judith S Hochman, David J Maron
BACKGROUND: Anatomic complete revascularization (ACR) and functional complete revascularization (FCR) have been associated with reduced death and myocardial infarction (MI) in some prior studies. The impact of complete revascularization (CR) in patients undergoing an invasive (INV) compared with a conservative (CON) management strategy has not been reported. OBJECTIVES: Among patients with chronic coronary disease without prior coronary artery bypass grafting randomized to INV vs CON management in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, we examined the following: 1) the outcomes of ACR and FCR compared with incomplete revascularization; and 2) the potential impact of achieving CR in all INV patients compared with CON management...
July 11, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37730297/reply-acetazolamide-in-acute-decompensated-heart%C3%A2-failure
#16
LETTER
Frederik H Verbrugge, Pieter Martens, Wilfried Mullens
No abstract text is available yet for this article.
September 26, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37730296/acetazolamide-in-acute%C3%A2-decompensated-heart%C3%A2-failure
#17
LETTER
Ramdas G Pai
No abstract text is available yet for this article.
September 26, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37730295/impact-of-socioeconomic-background-on-cardiovascular-health-promotion-in-early-childhood
#18
LETTER
Amaya de Cos-Gandoy, Gloria Santos-Beneit, Patricia Bodega, Jorge Baxter, Raquel Diaz-Munoz, Christopher A Hill, Isabel Carvajal, Carlos Peyra, Rodrigo Fernandez-Jimenez, Valentin Fuster
No abstract text is available yet for this article.
September 26, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37730294/ethics-in-cardiovascular-care-a-call-to-action
#19
EDITORIAL
Jorge R Alegria, B Hadley Wilson, R Scott Wright
No abstract text is available yet for this article.
September 26, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37730293/generalized-pairwise-comparisons-to%C3%A2-assess-treatment-effects-jacc%C3%A2-review%C3%A2-topic%C3%A2-of%C3%A2-the%C3%A2-week
#20
REVIEW
Johan Verbeeck, Mickaël De Backer, Jan Verwerft, Samuel Salvaggio, Marco Valgimigli, Pascal Vranckx, Marc Buyse, Edgar Brunner
A time-to-first-event composite endpoint analysis has well-known shortcomings in evaluating a treatment effect in cardiovascular clinical trials. It does not fully describe the clinical benefit of therapy because the severity of the events, events repeated over time, and clinically relevant nonsurvival outcomes cannot be considered. The generalized pairwise comparisons (GPC) method adds flexibility in defining the primary endpoint by including any number and type of outcomes that best capture the clinical benefit of a therapy as compared with standard of care...
September 26, 2023: Journal of the American College of Cardiology
journal
journal
20134
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.